86 related articles for article (PubMed ID: 28934212)
1. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study.
Fleury R; Bertail T; Bensalah K; Bernhard JC; Audenet F; Waeckel T; Parier B; Champy C; Olivier J; Doumerc N; Tricard T; Branger N; Bruyere F; Neuville P; Surlemont L; Alexandre Long J; Fontenil A; Vallee M; Roupret M; Boissier R; Jacques Patard J; Durand M; Ouzaid I; Rouget B; Durand X; Joncour C; Belas O; Denise Gomez F; Bigot P; Khene ZE;
Eur Urol Open Sci; 2024 Apr; 62():123-130. PubMed ID: 38496822
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV; Puri D; Cerrato C; Saidian A; Kobayashi M; Fukuda S; Fujii Y; Master V; Derweesh IH
Urol Oncol; 2024 Apr; 42(4):119.e1-119.e16. PubMed ID: 38341362
[TBL] [Abstract][Full Text] [Related]
4. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
Saitta C; Afari JA; Patil D; Tanaka H; Yuen KL; Wang L; Cortes J; Liu F; Mahmood M; Matian J; Mansour M; Puri D; Cerrato C; Nguyen MV; Hakimi K; Kobayashi M; Fukuda S; Meagher MF; Fujii Y; Master V; Derweesh IH
Clin Genitourin Cancer; 2024 Apr; 22(3):102098. PubMed ID: 38733897
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory response markers and survival prediction in patients with renal cell carcinoma.
Mountzias A; Hultdin J; Hlodan J; Kröger Dahlin BI; Johansson M; Ljungberg B
Scand J Urol; 2022 Feb; 56(1):47-52. PubMed ID: 34586034
[TBL] [Abstract][Full Text] [Related]
6. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma.
Wang Q; Zhang Y; Zhang B; Fu Y; Zhao X; Zhang J; Zuo K; Xing Y; Jiang S; Qin Z; Li E; Guo H; Liu Z; Yang J
Nat Commun; 2022 Jan; 13(1):31. PubMed ID: 35013217
[TBL] [Abstract][Full Text] [Related]
7. Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Duong NX; Le MK; Nguyen TT; Nguyen DD; Vuong HG; Kondo T; Mitsui T
Clin Genitourin Cancer; 2024 Feb; 22(3):102050. PubMed ID: 38502982
[TBL] [Abstract][Full Text] [Related]
8. A 20-year-old female with hemoptysis and high blood pressure: An unusual case of papillary renal cell carcinoma.
Olaniran K; Cheng W; Pulinthanathu R
Am J Case Rep; 2014; 15():254-7. PubMed ID: 24949115
[TBL] [Abstract][Full Text] [Related]
9. Papillary Renal Cell Carcinoma (PRCC): An Update.
Akhtar M; Al-Bozom IA; Al Hussain T
Adv Anat Pathol; 2019 Mar; 26(2):124-132. PubMed ID: 30507616
[TBL] [Abstract][Full Text] [Related]
10. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract][Full Text] [Related]
11. A Review of the Paradigmatic Role of Adipose Tissue in Renal Cancer: Fat Measurement and Tumor Behavior Features.
Faiella E; Vergantino E; Vaccarino F; Bruno A; Perillo G; Grasso RF; Zobel BB; Santucci D
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730649
[TBL] [Abstract][Full Text] [Related]
12. Rapid metachronous bladder metastasis of type 2 papillary renal cell carcinoma.
Elabbady A; Boudreau R; Mehrnoush V; Salem M; Fahmy A; Elabbady R; Kotb A
Arch Clin Cases; 2023; 10(2):93-96. PubMed ID: 37313126
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract][Full Text] [Related]
14. Expression of nectin-4 in papillary renal cell carcinoma.
Zschäbitz S; Mikuteit M; Stöhr C; Herrmann E; Polifka I; Agaimy A; Trojan L; Ströbel P; Becker F; Wülfing C; Barth P; Stöckle M; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Duensing S; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Schrader AJ; Hartmann A; Erlmeier F; Steffens S
Discov Oncol; 2022 Sep; 13(1):90. PubMed ID: 36136143
[TBL] [Abstract][Full Text] [Related]
15. Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort.
Zschäbitz S; Erlmeier F; Stöhr C; Herrmann E; Polifka I; Agaimy A; Trojan L; Ströbel P; Becker F; Wülfing C; Barth P; Stöckle M; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Schrader AJ; Mondorf Y; Hartmann A; Ivanyi P; Steffens S
J Cancer; 2022; 13(6):1706-1712. PubMed ID: 35399715
[TBL] [Abstract][Full Text] [Related]
16. Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience.
Radfar MH; Ameri F; Dadpour M; Khabazian R; Borumandnia N; Kabir SA
Cent European J Urol; 2021; 74(4):516-522. PubMed ID: 35083070
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models in papillary renal cell carcinoma.
Attalla K; Voss MH; Hakimi AA
Ann Transl Med; 2020 Nov; 8(21):1334. PubMed ID: 33313079
[No Abstract] [Full Text] [Related]
18. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
[TBL] [Abstract][Full Text] [Related]
19. Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.
Zhuang W; Liu N; Guo H; Zhang C; Gan W
BMC Urol; 2020 Aug; 20(1):130. PubMed ID: 32843027
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
